Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.
To investigate the effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques by histochemical examination and molecular imaging using (14)C-FDG and (99m)Tc-annexin A5.Irbesartan has a peroxisome proliferator-activated receptor gamma (PPARγ) activation property in addition to its...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3929710?pdf=render |
id |
doaj-b05c3cba9cba4af291a9de87b14a5bca |
---|---|
record_format |
Article |
spelling |
doaj-b05c3cba9cba4af291a9de87b14a5bca2020-11-25T02:29:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8933810.1371/journal.pone.0089338Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.Yan ZhaoAyahisa WatanabeSongji ZhaoTatsuo KobayashiKeita FukaoYoshikazu TanakaToru NakanoTetsuya YoshidaHiroshi TakemotoNagara TamakiYuji KugeTo investigate the effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques by histochemical examination and molecular imaging using (14)C-FDG and (99m)Tc-annexin A5.Irbesartan has a peroxisome proliferator-activated receptor gamma (PPARγ) activation property in addition to its ability to block the AT1 receptor. Accordingly, irbesartan may exert further anti-inflammatory and anti-apoptotic effects in atherosclerotic plaques. However, such effects of irbesartan have not been fully investigated. Molecular imaging using (18)F-FDG and (99m)Tc-annexin A5 is useful for evaluating inflammation and apoptosis in atherosclerotic plaques.Female apoE(-/-) mice were treated with irbesartan-mixed (50 mg/kg/day) or irbesartan-free (control) diet for 12 weeks (n = 11/group). One week after the treatment, the mice were co-injected with (14)C-FDG and (99m)Tc-annexin A5, and cryostat sections of the aortic root were prepared. Histochemical examination with Movat's pentachrome (plaque size), Oil Red O (lipid deposition), Mac-2 (macrophage infiltration), and TUNEL (apoptosis) stainings were performed. Dual-tracer autoradiography was carried out to evaluate the levels of (14)C-FDG and (99m)Tc-annexin A5 in plaques (%ID×kg). In vitro experiments were performed to investigate the mechanism underlying the effects.Histological examination indicated that irbesartan treatment significantly reduced plaque size (to 56.4%±11.1% of control), intra-plaque lipid deposition (53.6%±20.2%) and macrophage infiltration (61.9%±20.8%) levels, and the number of apoptotic cells (14.5%±16.6%). (14)C-FDG (43.0%±18.6%) and (99m)Tc-annexin A5 levels (45.9%±16.8%) were also significantly reduced by irbesartan treatment. Irbesartan significantly suppressed MCP-1 mRNA expression in TNF-α stimulated THP-1 monocytes (64.8%±8.4% of un-treated cells). PPARγ activation was observed in cells treated with irbesartan (134%±36% at 3 µM to 3329%±218% at 81 µM) by a PPARγ reporter assay system.Remissions of inflammation and apoptosis as potential therapeutic effects of irbesartan on atherosclerosis were observed. The usefulness of molecular imaging using (18)F-FDG and (99m)Tc-annexin A5 for evaluating the therapeutic effects of irbesartan on atherosclerosis was also suggested.http://europepmc.org/articles/PMC3929710?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yan Zhao Ayahisa Watanabe Songji Zhao Tatsuo Kobayashi Keita Fukao Yoshikazu Tanaka Toru Nakano Tetsuya Yoshida Hiroshi Takemoto Nagara Tamaki Yuji Kuge |
spellingShingle |
Yan Zhao Ayahisa Watanabe Songji Zhao Tatsuo Kobayashi Keita Fukao Yoshikazu Tanaka Toru Nakano Tetsuya Yoshida Hiroshi Takemoto Nagara Tamaki Yuji Kuge Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. PLoS ONE |
author_facet |
Yan Zhao Ayahisa Watanabe Songji Zhao Tatsuo Kobayashi Keita Fukao Yoshikazu Tanaka Toru Nakano Tetsuya Yoshida Hiroshi Takemoto Nagara Tamaki Yuji Kuge |
author_sort |
Yan Zhao |
title |
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. |
title_short |
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. |
title_full |
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. |
title_fullStr |
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. |
title_full_unstemmed |
Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5. |
title_sort |
suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoe-/- mice: molecular imaging with 14c-fdg and 99mtc-annexin a5. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
To investigate the effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques by histochemical examination and molecular imaging using (14)C-FDG and (99m)Tc-annexin A5.Irbesartan has a peroxisome proliferator-activated receptor gamma (PPARγ) activation property in addition to its ability to block the AT1 receptor. Accordingly, irbesartan may exert further anti-inflammatory and anti-apoptotic effects in atherosclerotic plaques. However, such effects of irbesartan have not been fully investigated. Molecular imaging using (18)F-FDG and (99m)Tc-annexin A5 is useful for evaluating inflammation and apoptosis in atherosclerotic plaques.Female apoE(-/-) mice were treated with irbesartan-mixed (50 mg/kg/day) or irbesartan-free (control) diet for 12 weeks (n = 11/group). One week after the treatment, the mice were co-injected with (14)C-FDG and (99m)Tc-annexin A5, and cryostat sections of the aortic root were prepared. Histochemical examination with Movat's pentachrome (plaque size), Oil Red O (lipid deposition), Mac-2 (macrophage infiltration), and TUNEL (apoptosis) stainings were performed. Dual-tracer autoradiography was carried out to evaluate the levels of (14)C-FDG and (99m)Tc-annexin A5 in plaques (%ID×kg). In vitro experiments were performed to investigate the mechanism underlying the effects.Histological examination indicated that irbesartan treatment significantly reduced plaque size (to 56.4%±11.1% of control), intra-plaque lipid deposition (53.6%±20.2%) and macrophage infiltration (61.9%±20.8%) levels, and the number of apoptotic cells (14.5%±16.6%). (14)C-FDG (43.0%±18.6%) and (99m)Tc-annexin A5 levels (45.9%±16.8%) were also significantly reduced by irbesartan treatment. Irbesartan significantly suppressed MCP-1 mRNA expression in TNF-α stimulated THP-1 monocytes (64.8%±8.4% of un-treated cells). PPARγ activation was observed in cells treated with irbesartan (134%±36% at 3 µM to 3329%±218% at 81 µM) by a PPARγ reporter assay system.Remissions of inflammation and apoptosis as potential therapeutic effects of irbesartan on atherosclerosis were observed. The usefulness of molecular imaging using (18)F-FDG and (99m)Tc-annexin A5 for evaluating the therapeutic effects of irbesartan on atherosclerosis was also suggested. |
url |
http://europepmc.org/articles/PMC3929710?pdf=render |
work_keys_str_mv |
AT yanzhao suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT ayahisawatanabe suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT songjizhao suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT tatsuokobayashi suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT keitafukao suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT yoshikazutanaka suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT torunakano suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT tetsuyayoshida suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT hiroshitakemoto suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT nagaratamaki suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 AT yujikuge suppressiveeffectsofirbesartanoninflammationandapoptosisinatheroscleroticplaquesofapoemicemolecularimagingwith14cfdgand99mtcannexina5 |
_version_ |
1724830807391993856 |